Detalhe da pesquisa
1.
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Cell
; 181(2): 236-249, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302568
2.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157962
3.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 379(2): 111-121, 2018 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860917
4.
Criteria for the use of omics-based predictors in clinical trials.
Nature
; 502(7471): 317-20, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24132288
5.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 373(21): 2005-14, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412349
6.
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group.
Lancet Oncol
; 15(4): e184-93, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24694642
7.
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
BMC Med
; 11: 220, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24228635
8.
Challenges in drug and biomarker co-development.
Recent Results Cancer Res
; 195: 229-39, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22527510
9.
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
J Natl Cancer Inst
; 113(4): 390-399, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32986828
10.
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
JAMA Oncol
; 6(3): 367-374, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566680
11.
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.
Eur J Cancer
; 114: 128-136, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31060925
12.
Biomarkers in early-phase trials: fundamental issues.
Bioanalysis
; 10(12): 933-944, 2018 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29923753
13.
Steps forward for cancer precision medicine.
Nat Rev Drug Discov
; 17(1): 1-2, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29170471
14.
Circulating Tumor DNA Assays in Clinical Cancer Research.
J Natl Cancer Inst
; 110(9): 929-934, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29931312
15.
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.
JCO Precis Oncol
; 22018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135159
16.
Societal challenges of precision medicine: Bringing order to chaos.
Eur J Cancer
; 84: 325-334, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28865260
17.
Cancer diagnostics: decision criteria for marker utilization in the clinic.
Am J Pharmacogenomics
; 5(6): 357-64, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16336001
18.
Bridging the gap: moving predictive and prognostic assays from research to clinical use.
Clin Cancer Res
; 18(6): 1531-9, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22422405
19.
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
J Natl Cancer Inst
; 103(22): 1656-64, 2011 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21960707
20.
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
Nat Med
; 14(8): 822-7, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18641660